AI Agent Index
ByHeather MacAvelia·Last verified May 2, 2026
Rayyan logo

Rayyan

4.3/ 5

by Rayyan

✓ Verified Review
Visit site

AI-powered systematic review platform with duplicate detection, AI screening, and collaboration. Free; Pro $8.33/seat/mo (annual); Student $4.99/seat/mo. 1M+ researchers globally.

From

Free

freemium

GitHub

Stars

G2

Rating

MCP

No

Compatible

Rayyan is the AI-powered systematic review platform purpose-built for academic researchers, evidence synthesis teams, and clinicians needing to conduct systematic literature reviews and meta-analyses at scale. Originally founded as an open-access systematic review tool by the Qatar Computing Research Institute, Rayyan has grown into one of the most-used systematic review platforms globally with 1+ million researchers across academic, healthcare, and research institutions, with positioning as the trusted standard for evidence synthesis workflows. Pricing follows a tiered subscription model with annual options (save up to 40%): Free covers early-career researchers with 3 active reviews, up to 2 reviewers/viewers per review, industry-leading duplicate detection, Legacy Compute Rating, workbench with 15+ facets and filters, and standard support. Pro at $8.33/seat/month annual ($99.99/year) covers active researchers with expanded reviews, more reviewers, advanced AI capabilities, and priority support. Student at $4.99/seat/month annual ($59.88/year) covers individual students with verification of academic affiliation. Institutional pricing is custom-priced for universities and research organizations. Rayyan's differentiation versus Covidence, DistillerSR, and other systematic review tools is the academic accessibility combined with strong AI capabilities and global research community: rather than positioning purely as enterprise systematic review software (Covidence pattern) or being limited to specific medical use cases (DistillerSR pattern), Rayyan combines academic-friendly pricing (free tier + student tier) with AI-powered duplicate detection, screening assistance, and collaboration features used across diverse research domains globally. This produces materially better accessibility for individual researchers and academic teams than enterprise-only alternatives. Rayyan capabilities include AI duplicate detection, AI screening recommendations, multi-reviewer collaboration with conflict resolution, full-text screening, advanced filtering and facets, citation export, integration with major reference managers (Zotero, Mendeley, EndNote), PRISMA flow diagram generation, and team management for institutional deployments. The platform serves academic researchers, evidence synthesis teams, clinicians, public health researchers, and institutional research teams globally. Rayyan operates under SOC 2 Type II, GDPR, and academic data handling compliance.

Pricing

freemium · Free

Segment

enterprise

Setup

easy

Verified

May 2, 2026

Capabilities

systematic-reviewliterature-reviewcitationsdata-analysis

Pros & Limitations

Editorial assessment

Pros

  • Academic-friendly pricing with free tier and student tier is genuinely differentiated — Free for early-career researchers and $4.99/seat student tier make systematic review tools accessible to individual researchers and graduate students that find Covidence or DistillerSR enterprise pricing prohibitive
  • Industry-leading duplicate detection — Rayyan's duplicate detection is widely regarded as the best in the systematic review category, materially better than alternatives that produce more false negatives in deduplication
  • 1M+ researcher installed base provides community resources and validation — extensive global adoption produces materially more learning materials, peer references, and methodology examples than smaller systematic review alternatives

Limitations

  • Less depth than enterprise systematic review tools (Covidence, DistillerSR) — Rayyan is solid for academic and SMB systematic review but lacks the workflow customization, advanced reporting, and enterprise-specific features that dedicated commercial alternatives provide for high-stakes regulatory and clinical work
  • Free tier limits create scaling friction — 3 active reviews and 2 reviewers per review on Free tier require upgrade for active research teams, meaningful for cost-conscious individual researchers but limiting for productive research operations
  • Specialized for systematic reviews limits broader research use cases — Rayyan is purpose-built for evidence synthesis and lacks the broader literature search, citation analysis, and AI research capabilities that horizontal AI research tools (Elicit, Scite.ai, SciSpace) provide

Technical Details

Deployment
web
Model architectureProprietary
Avg setup time< 30 minutes (sign up free, import first citation library from Zotero/Mendeley/EndNote, run duplicate detection, invite reviewers)
Autonomous rateConfigurable: Rayyan AI handles autonomous duplicate detection and screening recommendations; researchers approve all screening decisions and inclusions
Integrations
PubMedCochraneEMBASEZoteroMendeleyCSV imports
Security
SOC 2 Type IIGDPR

Similar agents

Rating

4.3/ 5

Editorial score

How we score this →

Industries

PharmaHealthcareEnterprise

Leave a review

Never displayed publicly.

Agent Stacks

See workflow stacks that feature Rayyan.

Compare

Related Content

Is this your tool?

Claim this listing to update your details and get a Verified badge.

Claim listing →